Extension of adaptive alpha allocation methods for strong control of the family‐wise error rate
Authors:
- 16 July 2012
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 32 (2) , 181-195
Abstract
With recent advancements in clinical trial design and the availability of rigorous statistical methods that provide strong control of the family‐wise type I error rate for multiple testing of hypotheses, it is now common for sponsors to design clinical trials with prospectively specified multiple testing of hypotheses of both primary and secondary endpoints and with the intent to obtain labeling claims for secondary endpoints. One of these recent advancements in multiple testing techniques is the adaptive alpha allocation approach (4A) proposed by Li and Mehrotra (Statistics in Medicine 2008; 27:5377–5391), which groups the hypotheses into two families on the basis of perceived trial power and allows the significance level for the second family to be set adaptively on the basis of the largest observed p‐value in the first family. We introduce a class of flexible functions that generalize the 4A procedure and can lead to relatively more powerful test statistics. In the case when the test statistics are correlated, we introduce well‐defined functions to calculate the significance level for the second family. The numerical computation for our methods is straightforward, making application in practice easy. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Design and Analysis Considerations in Clinical Trials With a Sensitive SubpopulationStatistics in Biopharmaceutical Research, 2010
- A flexible strategy for testing subgroups and overall populationStatistics in Medicine, 2008
- An efficient method for accommodating potentially underpowered primary endpointsStatistics in Medicine, 2008
- A flexible fixed-sequence testing method for hierarchically ordered correlated multiple endpoints in clinical trialsJournal of Statistical Planning and Inference, 2008
- The Fallback Procedure for Evaluating a Single Family of HypothesesJournal of Biopharmaceutical Statistics, 2005
- Gatekeeping strategies for clinical trials that do not require all primary effects to be significantStatistics in Medicine, 2003
- A fixed sequence Bonferroni procedure for testing multiple endpointsPharmaceutical Statistics, 2003
- Controlling alpha in a clinical trial: the case for secondary endpointsStatistics in Medicine, 2000
- Alpha calculus in clinical trials: considerations and commentary for the new millenniumStatistics in Medicine, 2000
- P-Value Interpretation and Alpha Allocation in Clinical TrialsAnnals of Epidemiology, 1998